Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study

被引:37
作者
Morotti, Matteo [1 ]
Remorgida, Valentino [1 ]
Venturini, Pier Luigi [1 ]
Ferrero, Simone [1 ]
机构
[1] IRCCS Azienda Osped Univ San Martino, Dept Obstet & Gynecol, IST Ist Nazl Ric Cancro, Genoa, Italy
关键词
Combined oral contraceptive; Desogestrel-only pill; Headache; Migraine without aura; Pain; Progestins; HORMONAL CONTRACEPTIVES; VENOUS THROMBOEMBOLISM; HEADACHE FREQUENCY; MENSTRUAL MIGRAINE; RISK; ENDOMETRIOSIS; EXPRESSION; IMPACT; COHORT; PAIN;
D O I
10.1016/j.ejogrb.2014.10.029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effect of a desogestrel progestogen-only pill (POP) compared to continuous combined oral contraception (COC) on migraine patterns in women with migraine without aura. Study design: A retrospective analysis of prospective headache charts from migrainous women who used the POP or COC in our clinic between July 2009 and July 2013. The quality and quantity of migraine attacks and use of medications were evaluated at three and six months. Health related quality of life was evaluated after 6 months' treatment. Results: Fifty-three patients were evaluable for the analysis (22 in the COC group and 31 in the POP group). Six months' POP treatment led to a statistical reduction in migraine days; headache days; pain intensity; number of days with severe pain and days with pain medication. The only statistical difference between the two groups was a reduction in the number of days with pain medication in the POP group compared to the COC group (p = 0.044). After 6 months' treatment a quality of life improvement was seen only in the POP group, but no statistical differences were found when comparing the two groups. Conclusions: Our preliminary data confirm that POP therapy improves migraine patterns and quality of life after 6 months' treatment in women with migraine without aura and it decreases the analgesic consumption with respect to an extended COC therapy. As POP represents a healthier opportunity, in terms of vascular risk, than combined contraception, its role in migrainous women deserves to be further investigated. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 36 条
  • [1] [Anonymous], 2006, Obstet Gynecol, DOI [10.1097/00006250-200606000-00055, DOI 10.1097/00006250-200606000-00055.PUBMED:16738183, DOI 10.1097/00006250-200606000-00055]
  • [2] DOUBLE-BLIND CONTROLLED TRIAL OF A MICRONIZED PREPARATION OF FLUMEDROXONE (DEMIGRAN) IN PROPHYLAXIS OF MIGRAINE
    BRADLEY, WG
    HUDGSON, P
    FOSTER, JB
    NEWELL, DJ
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1968, 3 (5617): : 531 - +
  • [3] Central changes associated with chronic pelvic pain and endometriosis
    Brawn, Jennifer
    Morotti, Matteo
    Zondervan, Krina T.
    Becker, Christian M.
    Vincent, Katy
    [J]. HUMAN REPRODUCTION UPDATE, 2014, 20 (05) : 737 - 747
  • [4] The Impact of Extended-Cycle Vaginal Ring Contraception on Migraine Aura: A Retrospective Case Series
    Calhoun, Anne
    Ford, Sutapa
    Pruitt, Amy
    [J]. HEADACHE, 2012, 52 (08): : 1246 - 1253
  • [5] Combined Hormonal Contraceptives: Is It Time to Reassess Their Role in Migraine?
    Calhoun, Anne
    [J]. HEADACHE, 2012, 52 (04): : 648 - 660
  • [6] Hormonal therapies for menstrual migraine
    Calhoun, Anne H.
    Hutchinson, Susan
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (05) : 381 - 385
  • [7] Davies Paul, 2003, J Br Menopause Soc, V9, P134
  • [8] Combined oral contraceptives in women with menstrual migraine without aura
    De Leo, Vincenzo
    Scolaro, Valeria
    Musacchio, Maria Concetta
    Di Sabatino, Alessandra
    Morgante, Giuseppe
    Cianci, Antonio
    [J]. FERTILITY AND STERILITY, 2011, 96 (04) : 917 - 920
  • [9] Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide
    Endrikat, Jan
    Gerlinger, Christoph
    Richard, Stephanie
    Rosenbaum, Peter
    Duesterberg, Bernd
    [J]. CONTRACEPTION, 2011, 84 (06) : 549 - 557
  • [10] Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy - A clinical review
    Gomes, MPV
    Deitcher, SR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) : 1965 - 1976